Pharma & Bio

Industry Update

Editor's comment

'Interesting times' beckon for pharma and biotech

The scale of pharmaceutical counterfeiting can be staggering to behold – whether in terms of the number of cases, the financial incentives or the economic loss to the legitimate industry.

Comment & Features

Integrating legacy data in the pharmaceutical sector

Pharmaceutical companies transitioning to electronic records need to be mindful that, convenient or not, their legacy equipment is critical to data integrity warns COPA-DATA’s Giuseppe Menin

Analysis

Case study: New cleanrooms prompt search for better monitoring system

During preparations for the construction of two new cleanroom facilities, NorthX Biologics, a leading Swedish biological drug manufacturer and process developer, reviewed its environmental monitoring…